NCT01515306 2022-03-08A Study of Ramucirumab (IMC-1121B) and Paclitaxel in Participants With Solid TumorsEli Lilly and CompanyPhase 2 Completed48 enrolled 17 charts
NCT01457118 2021-07-12An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 StudiesNektar TherapeuticsPhase 2 Completed27 enrolled 18 charts
NCT01567163 2014-10-16A Study of Ramucirumab and Docetaxel in Participants With Solid TumorsEli Lilly and CompanyPhase 2 Completed22 enrolled 15 charts